Rhinovirus-associated illness research hub

A randomized, double-blind, placebo-controlled Phase 2 study using the rhinovirus challenge model to investigate the efficacy and safety of 2-Deoxy-D-glucose as pre-exposure prophylaxis.

This study is testing a new medicine called 2-DG to see if it can help prevent common cold infections caused by a virus called rhinovirus. We want to find out if 2-DG is safe and effective in stopping people from getting sick.